Cargando…
Effect on Insulin-Stimulated Release of D-Chiro-Inositol-Containing Inositolphosphoglycan Mediator during Weight Loss in Obese Women with and without Polycystic Ovary Syndrome
Background. A deficiency of D-chiro-inositol-inositolphosphoglycan mediator (DCI-IPG) may contribute to insulin resistance in polycystic ovary syndrome (PCOS). Whether the relationship between impaired DCI-IPG release and insulin resistance is specific to PCOS rather than obesity is unknown. We asse...
Autores principales: | Cheang, Kai I., Sistrun, Sakita N., Morel, Kelley S., Nestler, John E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5046020/ https://www.ncbi.nlm.nih.gov/pubmed/27721826 http://dx.doi.org/10.1155/2016/7631804 |
Ejemplares similares
-
Management of polycystic ovary syndrome among Indian women using myo‐inositol and D-chiro-inositol
por: Vyas, Lila, et al.
Publicado: (2022) -
CONCERN: Does ovary need D-chiro-inositol?
por: Isabella, Rosalbino, et al.
Publicado: (2012) -
Targeting Metabolic Consequences of Insulin Resistance in Polycystic Ovary Syndrome by D-chiro-inositol and Emerging Nutraceuticals: A Focused Review
por: Davinelli, Sergio, et al.
Publicado: (2020) -
Expression of Concern to: Does ovary need D-chiro-inositol?
por: Isabella, Rosalbino, et al.
Publicado: (2018) -
Expression of Concern to: Does ovary need D-chiro-inositol?
por: Isabella, Rosalbino, et al.
Publicado: (2018)